Effect of HHV-6 and HHV-7 Infection on the Posttransplant Process and the Development of Complications in Patients after Autologous Stem Cell Transplantation / HHV-6 Un HHV-7 Infekcijas Ietekme Uz Pēctransplantācijas Klīnisko Gaitu Un Komplikāciju Attīstību Pacientiem Pēc Autologas Cilmes Šūnu Transplantācijas

Open access


The relationship between HHV-6 and HHV-7 reactivation and development of post-autologous peripheral stem cell transplantation complications was examined. The presence of viral genomic sequences in whole peripheral blood and cell free plasma was determined by nested PCR, HHV-6 and HHV-7 load by real-time PCR, virus specific antibodies and cytokines in serum by ELISA, and HHV-6 variants by restriction endonuclease analysis. Clinical features, reactivation of viruses and serum TNF- α, and IL-6 concentrations were determined in seventy-six patients with Roseolovirus infection before and after transplantation. Anti-HHV-6 antibodies were found in 62 of 76 (81.6%) patients before transplantation. A significantly higher rate of single HHV-7 infection was found in patients with viral infection in comparison with single HHV-6 infection (p = 0.0003) and concurrent (HHV-6 and HHV-7) infection (p = 0.0017). Complications after transplantation developed in 30.3% of patients and reactivation of viruses was detected in all of these patients. Significant increase of HHV-6 and HHV-7 reactivation with simultaneous increase of pro-inflammatory cytokines serum levels suggests that both viruses may be involved in the development of complications after autologous peripheral blood stem cell transplantation via their immunomodulatory ability. The kinetics of the Roseolovirus reactivation may reflect the potential role of HHV-7 as a co-factor for HHV-6 activation.

If the inline PDF is not rendering correctly, you can download the PDF file here.

  • Ablashi D. V. Balachandran N. Josephs S. F. Hung C. L Krueger G. R. Kramarsky B. Salahuddin S. Z. Gallo R. C. (1991). Genomic polymorphism growth properties and immunologic variations in human herpesvirus-6 isolates. Virology 184 545-552.

  • Anonymous (2008). The EBMT Handbook. 5th edn. Revised Edition. Genoa 199-215 pp.

  • Anonymous (2012). The EBMT Handbook. 6th edn. Genoa 197-213 pp.

  • Anonymous (2015). NCCN Guidelines for Prevention and Treatment of Cancer-Related Infections V.1.2015 - Follow-up - on 02/12/2015. Available at: http://www.nccn.org (accessed 01.03.2016).

  • Atedzoe B. N. Menezes J. DAddario M. Xu J. Ongradi J. Ahmad A. (1999). Modulatory effects of human herpesvirus-7 on cytokine synthesis and cell proliferation in human peripheral blood mononuclear cell cultures. J. Leukocyte Biol. 66 (5) 822-828.

  • Berneman Z. N. Ablashi D. V. Li G. Eger-Fletcher M. Reitz M. S. Jr Hung C. L. Brus I. Komaroff A. L. Gallo R. C. (1992). Human herpesvirus 7 is a T-lymphotropic virus and is related to but significantly different from human herpesvirus 6 and human cytomegalovirus. Proc. Natl. Acad. Sci. USA 89 10552-10556.

  • Boutolleau D. Fernandez C. Andre E. Imbert-Marcille B. M. Milpied N. Agut H. Gautheret-Dejean A. (2003). Human herpesvirus (HHV)-6 and HHV-7: Two closely viruses with different infection profiles in stem cell transplantation recipients. J. Infect. Dis. 187 179-186.

  • Carrigan D. R. Drobyski W. R. Russler S. K. Tapper M. A. Knox K. K. Ash R. C. (1991). Intersticial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. Lancet 338 147-149.

  • Carrigan D. R. Knox K. K. (1994). Human herpesvirus 6 (HHV-6) isolation from bone marrow: HHV-6 associated bone marrow suppression in bone marrow transplant patients. Blood 84 3307-3310.

  • Carrigan D. R. Drobyski W. R. Russler S. K. Tapper M. A. Knox K. K. Ash R. C. (1993). Interstitial pneumonitis associated with human herpesvirus-6 infection after marrow transplantation. J. Clin. Microbiol. 31 (6) 1515-1520.

  • Chapenko S. Folkmane I. Tomsone V. Kozireva S. Bicans J. Amerika D. Rozentals R. Murovska M. (2001). Infection of β-herpesviruses (CMV HHV-6 HHV-7): Role in postrenal transplantation complication. Transpl. Proc. 339 2463-2464.

  • Chapenko S. Folkmane I. Ziedina I. Chistyakovs M. Rozentals R. Krumina A. Murovska M. (2009). Association of HHV-6 and HHV-7 reactivation with the development of chronic allograft nephropathy. J. Clin. Virol. 46 (1) 29-32.

  • Folkmane I. Chapenko S. Amerika D. Bicans J. Murovska M. Rosentals R. (2001). Beta-herpesvirus activation after kidney transplantation with mycophenolate mofetil-based maintenance immunosuppression. Transplant Proc. 33 (3). 2384-2385.

  • Čistjakovs M. Èapenko S. Sultanova A. Nora Z. Roce A. Murovska M. (2009). Cilvçka sestâ herpesvîrusa (HHV-6) tipu sastopamîba daþâdu personu grupâs Latvijâ [Incidence of Human Herpesvirus 6 (HHV-6) in different persons groups in Latvia]. RSU Zinâtniskie raksti. RSU Rîga 317.-322.lpp. (in Latvian).

  • Dockrell D. H. Paya C. V. (2001). Human herpesvirus-6 and -7 in transplantation. Rev. Med. Virol. 11 23-26.

  • Fridrichs B. Tichelli A. Bacigalupo A. Russell N. H. Ruutu T. Shapira M. Y. Beksac M. Hasenclever D. Socie G. Schmitz N. (2010). Long-term outcome and late effects in patients with mobilised blood or bone marrow: A randomized trial. Lancet Oncol. 11 331-338.

  • Fujita A. Ihira M. Suzuki R. Enomoto Y. Sugiyama H. Sugata K. Suga S. Asano Y. Yagasaki H. Kojima S. Matsumoto K. Kato K. Yoshikawa T.(2008). Elevated serum cytokine levels are associated with human herpesvirus 6 reactivation in hematopoietic stem cell transplantation. J. Infect.. 57. 241-248.

  • Gojo I. Meisenberg B. Guo C. Fassas A. Murthy A. Fenton R. Takebe N. Heyman M. Philips G. L. Cottier-Fox M. Sarkodee-Adoo C. Ruehie K. French T. Tan M. Tricot G. Rappoport A. P. (2006). Autologous stem cell transplantation followed by consolidation chemotherapy for patients with multiple myeloma. Bone Marrow Transplant. 37 65-72.

  • Govern Mc Barbara. H. (eds.). (2016). Human herpesvirus 7 infection. Available at: http://www.herpes.com/hhv-7.html (accessed 01.03.2016).

  • Hall C. B. Caserta M. T. Schnabel K. C. McDermott M. .P Lofthus G. K. Carnahan J. A. Gilbert L. M. Dewhurst S. (2006). Characteristic and acquisition of human herpesvirus (HHV-7) infections in relation to infection with HHV-6. J Infect Dis. 193 1063-1069.

  • Humar A. Asberg A. Kumar D. Hartmann A. Moussa G. Jardine A. Rollag H. Mouas H. Gahlemann C. G. Pescovitz M. D. (2009). VICTOR Study Group. An assessment of herpesvirus co-infection in patients with CMV disease: Correlation with clinical and virologic outcomes. Amer. J. Transplant. 9 374-381.

  • Imbert-Marcille B. M. Tang X. W. Lepelletier D. Besse B. Moreau P. Billaudel S. Milpied N. (2000). Human herpesvirus 6 infection after autologous or allogeneic stem cell transplantation: A single-center prospective longitudinal study of 92 patients. Clin. Infect. Dis. 31 881-886.

  • Isomura H. Yosida M. Namba H. Yamada M. (2003). Interaction of human herpesvirus 6 with human CD34 positive cells. J. Med. Virol. 70 444-450.

  • Katsafanas G. S. Schirmer E. C. Wyatt L. S. Frenkel N. (1996). In vitro activation of human herpesviruses 6 and 7 from latency. Proc. Natl. Acad. Sci. USA 93 9788-9792.

  • Kozireva S. Nemceva G. Danilane I. Pavlova O. Blomberg. J Murovska M. (2001). Prevalence of blood-borne viral infections (cytomegalovirus human herpesvirus-6 human herpesvirus-7 human herpesvirus-8 human T-lymphotropic virus-I/II human retrovirus-5) among blood donors in Latvia. Ann. Hematol. 80 669-673.

  • Ljungman P. (2010). Molecular monitoring of viral infections after hematopoietic stem cell transplantation. Int. J. Hematol. 91 596-601.

  • Ljungman P. Hakki M. Boeckh M. (2010). Cytomegalovirus in hematopoietic stem cell transplant recipients. Infect. Dis. Clin. North Amer. 24 319-337.

  • Ljungman P. Camara R. Einsele H. Engelhard D. Ruesser P. Styczynski J. Ward K. (2011). Recommendations for CMV and HHV-6 management in patients with hematological diseases. 4th European Conference on Infections in Leukaemia. Available at: http://www.leukemia-net.org/content/treat_research/supportive_care/standards_sop_and_recommendations/e4702/infoboxContent5844/CMVECIL4updatefinal.pdf (accessed 01.03.2016).

  • Lusso P. (2006). HHV-6 and the immune system: mechanisms of immunomodulation and viral escape. J. Clin. Virol. 37 (Suppl. 1) 4-10.

  • Maeda Y. Teshima T. Yamada M. Harada M. (2000). Reactivation of human herpesviruses after allogeneic peripheral blood stem cell transplantation and bone marrow transplantation. Leuk. Lymphoma 39 229-239.

  • Mirandola P. Secchiero P. Pierpaoli S. Visani G. Zamai L. Vitale M. Capitani S. Zauli G. (2000). Infection of CD34(+) hematopoietic progenitor cells by human herpesvirus 7 (HHV-7). Blood 96 126-131.

  • Miyoshi H. Tanaka-Taya K. Hara J. Fujisaki H. Matsuda Y. Ohta H. Osugi Y. Okada S. Yamanishi K. (2001). Inverse relationship between human herpesvirus-6 and -7 detection after allogeneic and autologous stem cell transplantation. Bone Marrow Transplant. 27 1065-1070.

  • Movassagh M. Gozlan J. Senechal B. Baillou C. Petit J.-C. Lemoine F. M. (1996). Direct infection of CD34+ progenitor cells by human cytomegalovirus: Evidence for inhibition of hematopoiesis and viral replication. Blood 88 1277-1283.

  • Ongradi J. Kovesdi V. Kovats E. (2010). Human herpesvirus 7. Orv. Hetil. 151 645-651.

  • Rapaport D. Engelhard D. Tagger G. Or R. Frenkel N. (2002). Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients. Transpl. Infect. Dis. 41 10-16.

  • Razonable R. R. Rivero A. Brown R. A. Hart G. D. Espy M. J. van Cruijsen H. Wilson J. Groettum C. Kremers W. Smith T. F. Paya C. V. (2003). Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection. Clin. Transplant. 17 114-120.

  • Rasonable R. R. Lauteschlager I. (2010). Impact of human herpesvirus 6 in liver transplantation. World J. Hepatol. 2 345-353.

  • Rieger C. T. Rieger H. Kolb H. J. Peterson L. Huppmann S. Fiegl M. Ostermann H. (2009). Infectious complication after allogeneic stem cell transplantation: incidence in matched-related and matched-unrelated transplant settings. Transpl. Infect. Dis. 11 220-266.

  • Sassenscheidt J. Rohayem J. Illmer T. Bandt D. (2006). Detection of beta-herpesviruses in allogenic stem cell recipients by quantitative real-time PCR. J. Virol. Methods 138 40-48.

  • Schmitz N. Buske C. Gisselbrecht C. (2007). Autologous stem cell transplantation in lymphoma. Semin. Hematol. 449 234-245.

  • Secchiero P. Carrigan D. Asano Y. Benedetti L. Crowley R. W. Komaroff A. L. Gallo R. C. Lusso P. (1995). Detection of human herpesvirus 6 in plasma of children with primary infection and immunosuppressed patients by polymerase chain reaction. J. Infect. Dis. 171 273-280.

  • Studahl M. Bergstrom T. Ekeland-Sjoberg K.Ricksten A. (1995). Detection of cytomegalovirus DNA in cerebrospinal fluid in immunocompetent patients as a sign of active infection. J. Med. Virol. 46 274-280.

  • Tormo N. Solano C. de la Cámara R. Garcia-Noblejas A.Cardenoso L. Clari M. A. Nieto J. Lopez J. Hernández-Boluda J. C. Remigia M. J. Benet I. Navarro D. (2010). An assessment of the effect of human herpesvirus-6 replication on active cytomegalovirus infection after allogeneic stem cell transplantation. Biol. Blood Marrow Transplant. 16 653-661.

  • Wang L. R. Dong L. J. Zhang M. J. Lu D. P. (2008). Correlation of human herpesvirus 6B and CMV infection with acute GVHD in recipients of allogeneic haematopoietic stem cell transplantation. Bone Marrow Transplant. 42 673-677.

  • Witkowska A. M. (2005). On the role of sIL-2R measurements in rheumatoid arthritis and cancer. Mediators Inflamm. 3 121-130.

  • Xuan L. Huang F. Zhiping Fan Hongsheng Zhou (2012). Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies. J. Hematol. Oncol. 5 46.

  • Yoshikawa T. Ihira M. Ohashi M. Suga S. Asano Y. Miyazaki H. Hirano M. Suzuki K. Matsunaga K. Horibe K. Kojima S. Kudo K. Kato K. Matsuyama T. Nishiyama Y. (2001). Correlation between HHV-6 infection and skin rash after allogenic bone marrow transplantation. Bone Marrow Transplant. 28 77-81.

  • Zerr D. M. Corey L. Kim H. W. Huang M. L. Nguy L. Boeckh M. (2005). Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin. Infect. Dis. 40 932-940.

  • Zerr D. M. (2006). Human herpesvirus 6 and central nervous system in hematopoietic cell transplantation. J. Clin. Virol. 37 (Suppl 1) 552-556.

  • Zerr D. M. Boeckh M. Delaney C. (2012). HHV-6 reactivation and associated sequelae after hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 18 (11) 1700-1708.

Journal information
Impact Factor

CiteScore 2018: 0.3

SCImago Journal Rank (SJR) 2018: 0.137
Source Normalized Impact per Paper (SNIP) 2018: 0.192

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 314 180 3
PDF Downloads 110 70 1